Highest-materiality recent filing
Keen Vision Acquisition receives Nasdaq delisting notice; trading suspended Aug 3, 2026
Received Nasdaq notice on July 27, 2026 for non-compliance with SPAC 36-month deadline and minimum public float/holders rules.
KVAC shareholders approve extension to July 2027; 935,966 shares redeemed
Shareholders approved extending business combination deadline up to four additional three-month periods to July 27, 2027, with $30,000 deposit per extension.
Issued $120,000 unsecured promissory note to sponsor KVC Sponsor LLC on April 21, 2026 to fund trust account extension.
Keen Vision Acquisition enters LOI with Medera, extends merger deadline to April 30, 2026
Entered binding LOI with Medera Inc. and Novoheart Group, replacing the September 2024 merger agreement which was terminated.
Keen Vision Acquisition enters binding LOI for $100M merger with Novoheart
LOI replaces prior Sept 2024 Merger Agreement, which was terminated via mutual release.
At January 22, 2026 annual meeting, shareholders approved extending the business combination period up to two additional three-month periods to July 27, 2026.
Keen Vision extends business combination deadline to Jan 27, 2026 with $144,670 sponsor note
Issued $144,670.38 unsecured promissory note to sponsor KVC Sponsor LLC for trust account deposit.
Keen Vision Acquisition issues $144,670 promissory note to sponsor to extend trust account deadline
Issued unsecured promissory note of $144,670 to sponsor KVC Sponsor LLC to fund extension of business combination deadline.
Keen Vision extends business combination deadline to Nov 27, 2025 with $144.7K note from sponsor
Extended deadline to complete business combination to November 27, 2025.
Keen Vision extends SPAC deadline to Oct 27, 2025 with $144,670 sponsor note
Issued $144,670.38 promissory note to sponsor KVC Sponsor LLC to fund trust account extension.
Keen Vision sponsor deposits $144,670 into trust account to extend deadline
Sponsor wired $144,670.38 to trust account on August 27, 2025, for public shareholders.
Keen Vision SPAC issues $144,670 promissory note to sponsor to extend business combination deadline
Aggregate principal of $144,670.38 issued to KVC Sponsor LLC, non-interest bearing.
KVAC extends business combination deadline to Jan 2026; $144.7K note issued to sponsor
Shareholders approved extension of business combination period from July 27, 2025 to January 27, 2026.
Keen Vision issues $200K promissory note to extend business combination deadline to July 27, 2025
Issued $200,000 non-interest bearing promissory note to sponsor KVC Sponsor LLC.
SPAC Keen Vision extends business combination deadline to June 27, 2025 with $200K sponsor note
Issued $200,000 unsecured promissory note to sponsor KVC Sponsor LLC on May 20, 2025.
Keen Vision extends business combination deadline to May 27, 2025 via $200K note from sponsor
Issued $200,000 unsecured promissory note to sponsor KVC Sponsor LLC to fund trust extension.
Keen Vision extends business combination deadline to Apr 27 via $200K sponsor note
Issued $200,000 unsecured promissory note to sponsor KVC Sponsor LLC to fund trust extension.
Keen Vision extends business combination deadline to March 27, 2025 via $200K sponsor note
Issued $200,000 unsecured promissory note to sponsor KVC Sponsor LLC to fund trust extension.
Keen Vision extends business combination deadline to Feb 27, 2025 via $200K sponsor note
Issued $200,000 unsecured promissory note to sponsor KVC Sponsor LLC to extend deadline.
Keen Vision Acquisition extends business combination deadline to Jan 27, 2025 via $200K sponsor note
Issued $200,000 unsecured promissory note to sponsor KVC Sponsor LLC to extend business combination period.
Keen Vision Acquisition Corp extends deadline to Dec 27, 2024 via $200K sponsor note
Issued $200,000 unsecured promissory note to sponsor KVC Sponsor LLC to extend business combination period.
Keen Vision extends business combination deadline to July 2025; 8.5M shares redeemed
Shareholders approved extending the business combination deadline from Oct 27, 2024 to July 27, 2025 via monthly $200k deposits.
Keen Vision Acquisition Corp. adjourns annual meeting to Oct 25, 2024
Annual general meeting called to order Oct 24, 2024, adjourned to Oct 25, 2024, at 10:00 AM ET.
Keen Vision Acquisition Corp. to merge with Medera Inc. in deal valued at $622.6M
Medera valued at $622.56M; each Acquirer Ordinary Share valued at $10.00.
KVAC signs non-binding LOI to merge with Boston clinical-stage biopharma company
On March 22, 2024, KVAC entered a non-binding LOI for a potential business combination with a clinical-stage biopharma target.
SPAC Keen Vision director LI resigns; CHU appointed to board and committees
LI, Ronald Adolphus resigned as director and from Audit, Compensation, Nominating committees on March 13, 2024; no disagreement with company.
Keen Vision Acquisition Corporation dismisses auditor Marcum, appoints Adeptus Partners
On Sept 13, 2023, Audit Committee dismissed Marcum LLP as independent registered public accounting firm.
Keen Vision Acquisition Corp. closes IPO, deposits $151.4M trust; going concern noted
IPO of 14.95M units at $10.00/unit; gross proceeds $149.5M including full over-allotment.
Keen Vision closes $149.5M SPAC IPO; 14.95M units at $10; over-allotment fully exercised
Closed IPO of 14,950,000 units at $10.00/unit, gross proceeds of $149,500,000.
On March 13, 2024, the Board appointed CHU, William as a director of the Board, including committee positions as a member on the Audit Committee and the Compensation Committee, and as Chairman on the Nominating Committee, effective immediately.
On March 13, 2024, Professor LI, Ronald Adolphus resigned from his positions as a director of the board of directors (the “ Board ”) of the Keen Vision Acquisition Corporation (the “ Company ”), including from his committee positions on the Audit Committee, Compensation Committee, and the Nominating Committee, effective immediately.
Max materiality 0.85 · Median 0.50 · Most common event other_material